Pasar al contenido principal

TRAZABILIDAD DE LA PRESENCIA DE ANTIBIOTICOS EN LECHE, QUESO Y LACTOSUERO DE CABRA

AGL2013-45147-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2013
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario UNIVERSITAT POLITÈCNICA DE VALÈNCIA
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Antibiotic residues in milk and cheeses after the off-label use of macrolides in dairy goats

  • Quintanilla-Vázquez, Paloma Galicia
  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Peris Palau, Bernardo
  • Rodríguez Garcia, Martín|||0000-0001-6079-9238
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[EN] The limited availability of drugs registered for dairy goats makes veterinarians prescribe off-label treatments with a legally established minimum safety period of seven days. The aim of this work was to verify if the exceptional use of macrolide antibiotics in dairy goats generates residues in milk and cheeses within that period. Hence, three macrolide drugs (erythromycin, tylosin and spiramycin) were administred in an in vivo experiment in dairy goats. Ripened cheeses were made from bulk milk obtained before drug administration, 24¿h after treatment, and at the end of the recommended withdrawal period. Residual amounts of erythromycin (234.9¿±¿52.7¿¿g/kg), tylosin (198.7¿±¿57.8¿¿g/kg) and spiramycin (1539.8¿±¿469.4¿¿g/kg), widely exceeding their legal maximum residue limits (MRLs) established, were detected in milk collected 24¿h after treatment, making the cheese production in most cases impossible. After the seven-day period, only spiramycin was detected in goat¿s milk (79.6¿±¿19.2¿¿g/kg) although no antibiotic residues were found in the cheeses. A withdrawal time of seven days seems suitable to guarantee milk safety after the administration of erythromycin and tylosin without any negative effects neither on the milk nor on the and cheese properties. However, given the rapid elimination of these substances, a shorter withdrawal period might be considered. For spiramycin, persisting in milk for a longer period, further studies on its pharmacokinetics in dairy goats would be recommendable to avoid a potential risk to consumer health., This work is part of the AGL-2013-45147-R funded by Ministerio de Ciencia e Innovacion (Madrid. Spain). The authors thank the 'Program of Support for Research and Development' (PAID-2014, UPV) for support P. Quintanilla PhD studies at Universitat Politecnica de Valencia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Influence of enrofloxacin on the coagulation time and the quality parameters of goat&apos, s milk yoghurt

  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Escriche Roberto, Mª Isabel|||0000-0003-0180-0360
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
  • Morari-Pirlog, A.
  • Quintanilla-Vázquez, Paloma Galicia
[EN] Three batches of yoghurts were made from goat s milk with different enrofloxacin concentrations (0, 50, 100 and 150 lg/kg). Quality parameters were analysed at 1, 7, 14 and 28 days at 5 °C. Drug residues were also quantified by HPLC. Coagulation time and most yoghurt properties remained unaffected by the presence of enrofloxacin in goat s milk. However, quality parameters were affected by the storage period. 74.9 99.2% of enrofloxacin initially added to goat s milk remained in the yoghurt throughout its entire shelf life, potentially posing a risk to consumer health. Therefore, an enrofloxacin maximum residue limit in yoghurt should be established.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Characteristics of ripened Tronchon cheese from raw goat milk containing legally admissible amounts of antibiotics

  • Quintanilla-Vázquez, Paloma Galicia
  • Molina Casanova, A.M.
  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Escriche Roberto, Mª Isabel|||0000-0003-0180-0360
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[EN] The aim of this study was to evaluate the transfer of the most widely used antibiotics in dairy goats from milk to cheese as well as their effect on the cheese-making process and cheese characteristics during ripening. Antibiotic-free milk was spiked individually with 7 veterinary drugs (amoxicillin, benzylpenicillin, cloxacillin, erythromycin, ciprofloxacin, enrofloxacin, and oxytetracycline) at an equivalent concentration of the European Union maximum residue limit. Spiked goat milk was used to make mature Tronchon cheeses, which were analyzed at 0, 30, and 60 d of maturation to determine pH, chemical composition, proteolytic and lipolytic activities, and color and textural properties. A sensory evaluation of 60-d ripened cheeses was carried out. Cheeses from raw antibiotic-free goat milk were made simultaneously to be used as reference. The cheese-making process was unaffected by the presence of most antibiotics evaluated. Only erythromycin and oxytetracycline significantly increased the time required for cheese production (122 +/- 29 and 108 +/- 25 min, respectively). However, variable amounts of antibiotics, ranging from 7.4 to 68%, were transferred from milk to cheese, with oxytetracycline and quinolones showing the highest retention rates. In general, antibiotic residues present in the cheeses at the beginning of maturation decrease significantly along time. Thus, beta-lactams and erythromycin residues were not detectable after 30 d of ripening. However, relatively high concentrations of enrofloxacin (148 +/- 12 mu g/kg) and ciprofloxacin (253 +/- 24 mu g/kg) residues were found in the cheeses after 60 d of maturation. The quality characteristics of the Tronchon cheeses were only slightly affected by such substances, with few significant differences in the free fatty acid concentration and color and textural properties of the cheeses. Results herein indicate that the use of goat milk containing antibiotics, such as quinolones, at the European Union maximum residue limit for cheese production could adversely affect the safety of the final products because relatively high concentrations of these substances could be retained in soft and semi-mature cheeses, making it necessary to assess the risk for consumer health. Studies on the partition of the antibiotic substances during cheese-making, using specific technologies, would be convenient to guarantee the safety of cheese and related products., This work is part of the AGL-2013-45147-R Project funded by Ministerio de Ciencia e Innovación (Madrid, Spain). P. Quintanilla thanks Universitat Politècnica de València (Valencia, Spain) for the grant received for the development of this work (PAID-2014, UPV).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Performance of Eclipse Farm test coupled with e-Reader for screening antibiotics in sheep ang goat&apos, s milk, Evaluation de la performance du test Eclipse Farm 3G couplé avec le lecteur e-Reader pour le dépistage d&apos, antimicrobiens dans le lait de brebis et de chèvre

  • Giraldo, J.
  • Cabizza R.
  • Sanz, D.
  • Mata, L.
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[Otros] La présence de résidus d'antimicrobiens dans le lait représente un problème technologique pour la filière laitière et un risque pour la santé publique. De nombreuses méthodes ont été développées pour analyser les résidus d'antibiotiques dans le lait de vache, cependant ces méthodes ne fonctionnent pas toujours correctement avec le lait de brebis et de chèvre. Dans ce travail, nous présentons une évaluation sur la performance d'un nouveau système de dépistage de résidus d¿antibiotiques dans le lait de brebis et de chèvre. Le nouveau système combine un test d'inhibition microbienne (Eclipse Farm) et un dispositif (e-Reader) qui intègre une incubation à 65ºC et une surveillance continue du changement de la couleur du test. La performance du test a été validée conformément à la décision 2002/657/CE de la Commission Européenne. La sensibilité a été évaluée sur 12 molécules provenant de plusieurs familles d¿antimicrobiens. Dans tous les cas, les limites de détection calculées étaient proches aux limites autorisées (Limite Maximale de Résidus). Les capacités de détection (CCß) ont été également déterminées pour 7 molécules représentant les principaux groupes d¿antimicrobiens utilisés dans l'élevage laitier (pénicillines, céphalosporines, aminoglycosides, tétracyclines, sulfamides et macrolides). La plupart des molécules ont été détectées au niveau de la LMR. L¿Eclipse Farm combiné avec le e-Reader est donc un test à large spectre, qui permet de couvrir la détection d¿un nombre important de molécules d¿antimicrobiens dans le lait de brebis et de chèvre., [EN] The presence of antibiotic residues in milk is a concern due to technological and health reasons. Although many methods have been developed to analyse antibiotic residues in cow milk, such methods not always work correctly with sheep and goat¿s milk. Herein, we presented a study of the performance of a new system for the screening of antimicrobial residues in sheep and goat¿s milk. The method combines a microbial inhibitor test (Eclipse Farm) and a device (e-Reader) that integrates incubation at 65ºC and continuous monitoring of the colour change. The performance of the new system was validated according to the European Commission Decision 2002/657/EC. Sensitivity of the new system was evaluated on 12 molecules from several families of antimicrobials. The detection limits were close to the European maximum residue limits (MRL). Detection capabilities (CCß) were also determined for 7 molecules representing the main antimicrobial groups used in dairy husbandry (penicillins, cephalosporins, tetracyclins, sulphonamides and macrolides). Most of the molecules were detected at the MRL level. The Eclipse Farm coupled to e-Reader has shown to be a valuable tool for screening a broad-spectrum of antimicrobial residues in sheep and goat milk.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Antimicrobial activity in cheese whey as an indicator of antibiotic drug transfer from goat milk

  • Giraldo-Gómez, Jennifer
  • Althaus, Rafael Lisandro
  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[EN] Raw goat milk spiked with antibiotics was coagulated with rennet, the whey separated and the transfer of 18 antibiotics from the milk to the whey was evaluated by estimating antimicrobial activity of the whey using microbial inhibitor tests. Antibiotic-free whey (negative whey) spiked with different antibiotics was used as a reference. The antimicrobial activity in whey from milk spiked with most b-lactam drugs was lower (0e40%) than that of the reference whey, suggesting that these antibiotics are mostly released from curd and transferred to the whey. However, for most non-b-lactam drugs, an 84e100% reduction in the relative antimicrobial activity in whey was obtained, indicating the higher susceptibility for retention in curd. The traceability of antibiotics through the cheese-making process will make it possible to determine whether control systems are required to prevent the negative implications of the presence of antibiotic drug residues in cheese and whey products., This work is part of the AGL-2013-45147-R funded by the Ministry of Science and Innovation (Madrid. Spain). The authors are grateful to Zeulab, S. L. (Zaragoza, Spain) for their support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Validation of a microbiological inhibition system based on Eclipse Farm 3G coupled with e-Reader to screening B-lactam and tetracycline antibiotics in goat&apos, s cheese whey, Validation d&apos, un système d&apos, inhibition microbiologique basé sur Eclipse Farm 3G couplé avec un lecteur e-Reader pour le dépistage des antibiotiques ß-lactam et tetracycline dans le lactosérum de fromage de chèvre

  • Giraldo, J.
  • Cabizza, R.
  • Mata, L.
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[EN] The presence of antimicrobial residues in milk and dairy products could cause negative technological effects and represents a risk for consumer health. During the cheese-making process, antibiotics could be retained in curd or eliminated in whey to a greater or lesser extent. Whey is a by-product used in the manufacture of foodstuffs for human consumption and animal feeding and therefore, the presence of antibiotic residues in this product should be controlled. Thus, it is crucial to develop an analytical strategy to screen antibiotics in whey. A new system for screening antibiotics in raw milk was recently developed, in which a microbial inhibitor tube test (Eclipse Farm) and a device (e-Reader) are coupled. The new system allows the incubation of the test and a continuous monitoring of the test colour change. The aim of this work was to study the performance of the new system for the detection of ß-lactam and tetracycline residues in goat¿s cheese whey. A preliminary study demonstrated the necessity to include a one-hour diffusion period at room temperature. The performance was validated in agreement with European Commission Decision 2002/657/EC. Specificity of microbial test was evaluated by analysing one hundred and thirty whey samples. Results showed a low percentage of false-positive results. The detection limits for amoxicillin, benzilpenicillin, cephalexin and oxytetracycline in goat¿s cheese whey were calculated and the detection capabilities (CCß) were below or at the MRL levels, with the exception of amoxicillin, which was slightly above them. In conclusion, Eclipse Farm coupled to e-Reader represents an appropriate method to screen ß-lactams and tetracycline residues in whey., [Otros] La présence de résidus d'antibiotiques dans le lait et les produits laitiers peut entraîner des problèmes technologiques et un risque pour la santé des consommateurs. Pendant le processus de fabrication du fromage, les antibiotiques peuvent rester attachés au caillé ou peuvent être éliminés dans le sérum. Le lactosérum est un sous-produit utilisé dans la fabrication de denrées alimentaires destinées à la consommation humaine et à l'alimentation animale et, par conséquent, la présence de résidus d'antibiotiques dans ce produit doit être bien contrôlée. Il est donc essentiel de mettre en place une stratégie analytique pour l'analyse des antibiotiques dans le lactosérum. Un nouveau test d'inhibition microbienne (Eclipse Farm) couplé avec un dispositif d'incubation et de lecture (e-Reader) a été récemment développé pour le dépistage d'antibiotiques dans le lait cru. Le nouveau système permet l'incubation et la surveillance continue du changement de la couleur du test. L'objectif de ce travail consistait à étudier la performance du nouveau système pour la détection des résidus de ß-lactames et de tétracyclines dans le lactosérum du fromage de chèvre. Une étude préliminaire a démontré la nécessité d'inclure une étape de diffusion d'une heure à température ambiante. Le système a été validé conformément aux procédures décrites dans la décision 2002/657/CE de la Commission Européenne. La spécificité du test a été évaluée en analysant 130 échantillons de lactosérum. Les résultats ont montré un faible pourcentage de résultats faussement positifs. Les limites de détection pour l'amoxicilline, la benzilpenicilline, la céphalexine et l'oxytétracycline dans le lactosérum du fromage de chèvre ont été calculées, ainsi que les capacités de détection (CCß), toutes en dessous ou au même niveau que les Limites de Résidus Maximum (LRM), sauf pour l'amoxicilline, avec une limite légèrement supérieure. En conclusion, Eclipse Farm couplé à e-Reader représente une méthode appropriée pour la détection des résidus des ß-lactames et tétracyclines dans le lactosérum de chèvre.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Food safety margin assessment of antibiotics: Pasteurized goat&apos, s milk and fresh cheese

  • Quintanilla-Vázquez, Paloma Galicia
  • Doménech Antich, Eva Mª|||0000-0003-3560-6355
  • Escriche Roberto, Mª Isabel|||0000-0003-0180-0360
  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[EN] Traces of antimicrobials in milk are of great concern for public health. The European Union has established maximum residue limits in milk; these, however, by themselves do not guarantee the absence of drug residues in milk and related products. Currently, very little information is available on the transfer of antibiotic residues from milk to other dairy products and their potential effect on food safety. This work evaluated the presence of antibiotic residues in pasteurized fluid milk and fresh cheeses from goat's milk containing these veterinary drugs at legal safety levels (maximum residue limits) and assessed the safety margin of these dairy products for consumers. Eight antibiotics (amoxicillin, benzylpenicillin, cloxacillin, neomycin, erythromycin, ciprofloxacin, enrofloxacin, and oxytetracycline) were selected, and three batches of fresh cheese were made from pasteurized goat's milk spiked with each of these drugs. Drug residues in milk and cheese samples were analyzed by liquid chromatography¿tandem mass spectrometry. The safety margin of goat's milk products was calculated taking into account different age groups (children, teenagers, and adults). Results showed that most antibiotics present in raw milk remained in pasteurized milk and were transferred to cheese to a high extent; retention was above 50% in most cases. The minimum safety margin in pasteurized milk was obtained for enrofloxacin, ciprofloxacin, and erythromycin for the children's group. For fresh cheese, an elevated safety margin was obtained for all antibiotics and age groups considered. However, the large amounts of antibiotics retained in the cheese might contribute to the development and spread of antimicrobial resistance. Considering the differences in milk from different species and the great variety of cheeses, it would be advisable to continue the traceability study of antibiotics in order to increase the safety margin of dairy products., This work is part of AGL-2013-45147-R, funded by the Ministry of Science and Innovation (Madrid, Spain). The authors thank Universitat Politecnica de Valencia (Program of Research and Development, FPI-2014) for funding the Ph.D. scholarship FPI-2014 attained by P. Quintanilla.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Interferences on microbial inhibitor tests related to ivermectin treatment in lactating dairy goats

  • Romero Rueda, Tamara
  • Moya, V.J.|||0000-0002-6769-0515
  • Fernández Martínez, Nemesio|||0000-0001-7150-2903
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
  • Althaus, Rafael Lisandro
  • Reybroeck, Wim
[EN] This Research Communication reports interferences related to the administration of ivermectin in lactating dairy goats on the response of microbial tests for screening antibiotics in milk. Twenty-eight Murciano-Granadina goats, naturally infested with Sarcoptes scabiei var. caprae, were treated with a subcutaneous injection of ivermectin (200 mu g/kg b.w.). To prevent re-infestation, a second dose was applied 7 d later. Individual milk samples were collected, daily, up to 15 d post-treatment. Milk samples were analysed by microbial inhibitor tests (BRT MRL, Delvotest SP-NT MCS and Eclipse 100) and ivermectin residues were quantified by HPLC. A large number of positive results were obtained for all microbial tests, especially on the first day after treatment (BRT MRL = 464%; Delvotest SP-NT MCS = 143%; and Eclipse 100 = 178%). However, the highest concentration of drug residues in milk (243 ng/ml) was detected on the tenth day after treatment, when positive outcomes were relatively lower (BRT MRL = 178%; Delvotest SP-NT MCS = 107%; and Eclipse 100 = 74%). Results herein suggest that factors related to the ivermectin treatment other than drug residues in milk, or alterations produced by the parasitic disease itself affecting the immune response of animals, could be the cause of false-positive results in microbial tests. It can be concluded that the application of ivermectin in dairy goats infested with sarcoptes mange during lactation produces persistent drug residues in milk, and could also cause false-positive results in microbial inhibitor tests for screening antibiotics., This work is part of the AGL-2009-11524 funded by the Ministry of Science and Innovation (Madrid, Spain) and the Generalitat Valenciana (ACOMOP/2012/164, Valencia, Spain).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Quinolones in goats&apos, milk: Effect on the cheese-making process, chemical and microbial characteristics of acid-coagulated cheeses

  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
  • Montes-Estellés, Rosa M|||0000-0002-4599-6644
  • Sanna, A.
  • Quintanilla, P.
[EN] The effect of the presence in goats' milk of enrofloxacin and ciprofloxacin on cheese-making and the characteristics of acid-coagulated cheeses was evaluated. Raw goats' milk was spiked with quinolones at maximum residue limit concentration (100 ¿g kg¿1). For each antibiotic, three batches of cheese were made by acid coagulation (pH 4.6) using a commercial starter culture. Cheese-making process, gross composition and microbial counts in the cheeses were unaffected by the presence of quinolones in milk. However, relatively high amounts of these substances were retained in the cheeses, with residual concentrations of 146.5 ± 4.9 ¿g kg¿1 and 150.7 ± 25.7 ¿g kg¿1 for enrofloxacin and ciprofloxacin, respectively, after 20 days of maturation. Results suggest that the use of goats' milk containing legally admissible amounts of enrofloxacin and/or ciprofloxacin would have no impact on cheese manufacturing, composition and microflora of acid-coagulated cheese. However, the transfer of these substances to the final products could compromise consumer safety., The authors are grateful for the financial support by the Ministerio de Ciencia e Innovacion (Madrid, Spain) project AGL-2013-45147-R.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Volatile profile of matured Tronchón cheese affected by oxytetracycline in raw goat milk

  • Quintanilla-Vázquez, Paloma Galicia
  • Hettinga, K.A.
  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Escriche Roberto, Mª Isabel|||0000-0003-0180-0360
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[EN] The presence of antibiotics in milk destined for cheese production may affect the biological processes responsible for the formation of volatile compounds, leading to alterations in the characteristic cheese flavor expected by consumers. The aim of this study was to evaluate the effect of the presence of oxytetracycline in goat milk on the volatile profile of ripened cheeses. Traditional mature Tronchón cheeses were manufactured from raw goat milk spiked with different concentrations of oxytetracycline (50, 100, and 200 ug/kg). Cheese made from antibiotic-free goat milk was used as control. We analyzed the residual amounts of the antibiotic and the volatile profile of the experimental cheeses on a fortnightly basis during maturation using liquid chromatography tandem mass spectrometry and then solid-phase microextraction followed by gas chromatography-mass spectrometry. Our results suggested that oxytetracycline was widely transferred from milk to cheese: drug concentrations in the cheeses were 3.5 to 4.3 times higher than those in raw milk. Although the residual amounts of oxytetracycline significantly decreased during maturation (88.8 to 96.5%), variable amounts of residues remained in cheese matured for 60 d (<10 to 79 ug/kg). In general, the presence of oxytetracycline in goat milk did not affect the volatile profile of Tronchón cheeses; volatile profile was significantly modified by ripening time. Still, the presence of oxytetracycline residues in cheeses ripened for 60 d could be of great concern for public health., This work is part of the AGL-2013-45147-R funded by the Ministry of Science and Innovation (Madrid. Spain). The authors thank the Research and Development Support Program, "Ayudas para movilidad dentro del Programa para la Formación de Personal Investigador" (2.016) of Universitat Politècnica de València (Spain), allowing Paloma Quintanilla to perform a predoctoral stay at the Food Quality and Design Group, Wageningen University and Research (Wageningen, the Netherlands). The authors state that they have no conflicts of interest.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Enrofloxacin Treatment on dairy goats: Presence of antibiotic in milk and impact of residue on technological process and characteristics of mature cheese

  • Quintanilla-Vázquez, Paloma Galicia
  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Escriche Roberto, Mª Isabel|||0000-0003-0180-0360
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[EN] Lately quinolones, particularly enrofloxacin, have been incorporated as a veterinary treatment of small ruminants, like goats, whose milk is highly appreciated for the manufacture of traditional cheeses. This study aims to evaluate the influence of the presence of enrofloxacin in milk (from goats previously treated with this antibiotic), on the characteristics (chemical composition; colour, texture, volatile profile and sensory evaluation) of mature cheese at 0, 30 and 60 days. Three batches of cheeses were made from milk obtained at three different times with respect to the animals¿ antibiotic administration (24 h before treatment, 24 h after treatment, and after the withdrawal period). The manufacture process of cheese is not affected by enrofloxacin in any way; therefore, it will remain unnoticed in the production line. A transfer of enrofloxacin, and its metabolite ciprofloxacin, to the cheese produced with milk obtained 24 h after treatment was observed. The presence of antibiotic residues does not produce significant changes in any of its compositional, texture and colour characteristics, when compared to the cheeses made before veterinary treatment with antibiotic-free milk, with the only exception of some compounds of the volatile fraction. Enrofloxacin and its metabolite show high stability during the cheese maturation (51% of both remain after 60 days of ripening). In general, the presence of this antibiotic has lesser effects on all the characteristics of the cheese compared to those modifications produced during the maturation time. Sensory measures of odour, colour, appearance and texture attributes, as well as the global preference, are also not affected by this antibiotic, which would imply a risk for the population since its presence would go undetected., This work is part of the AGL-2013-45147-R Project funded by Ministerio de Ciencia e Innovación (Madrid. Spain). P. Quintanilla thanks Universitat Politècnica de València for the grant received for the development of this work (PAID-2014, UPV).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Effect of the presence of neomycin in goat¿s milk on the making and characteristics of Tronchón chees, Effet de la présence de néomycine dans le lait de chèvre sur la fabrication et les caractéristiques du fromage Tronchón

  • Quintanilla-Vázquez, Paloma Galicia
  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
  • Peris Palau, Bernardo
  • Escriche Roberto, Mª Isabel|||0000-0003-0180-0360
  • Molina Pons, Mª Pilar|||0000-0002-0647-8609
[Otros] La présence de résidus d'antibiotiques dans les produits laitiers peut constituer un problème pour la santé publique et pour l'industrie laitière. Dans ce travail, nous avons évalué l'effet de la présence de néomycine dans le lait de chèvre sur la fabrication et les caractéristiques du fromage Tronchón. Les fromages ont été fabriqués, en double exemplaire, à partir du lait de chèvre cru sans antibiotiques et avec l'addition de néomycine à la limite maximale de résidu (1500 ug/kg). Nous avons étudié les changements dans les caractéristiques du fromage et la présence de résidus à différentes périodes de maturation (1, 30 et 60 jours). La durée du procédé de fabrication augmentait (48 ± 18 min) sous l'effet de la présence de néomycine dans le lait de chèvre. Concernant les caractéristiques du fromage, nous avons observé une diminution dans les valeurs de l'activité de l¿eau ainsi qu¿une réduction dans les concentrations d'acides gras libres et d'acides aminés libres dans les fromages avec l'antibiotique, en suggérant une activité biochimique mineure pendant la maturation. Nous avons aussi observé une plus grande légèreté, moins rougeur et une plus faible élasticité dans ce type de fromage. En plus, pendant la maturation, les concentrations de néomycine dans le fromage augmentaient 4,9 fois par rapport à la concentration initiale dans le lait, ce qui pourrait impliquer un risque pour la santé publique., [EN] Antibiotic residues in milk and dairy products are a potential problem for public health, and for the dairy industry. This study investigated the effect of the presence of neomycin in goat's milk on the production and characteristics of semi-hard Tronchón cheese. Cheeses were made, in duplicate, from raw goat's milk without antibiotics and with addition of neomycin at the Maximum Residue Limit (1500 ug/kg). Possible chan ges in the characteristics and the presence of antibiotic residues in the cheeses were evaluated at different time points along ripening (1, 30 and 60 days). Processing time was increased (48 ± 18 min) by the presence of neomycin in milk. Regarding cheeses, lower values of water activity as well as reduced free fatty acids and free amino-acid concentrations were detected in cheeses from milk with the antibiotic, suggesting a minor biochemical activity throughout ripening. Thus, a greater lightness and lower redness value were observed in this type of cheese, also presenting lower springiness. Moreover, high concentrations of neomycin were retained in the cheese and concentrated during ripening, leading to a concentration factor of 4.9, with respect to the initial concentration in the milk, potentially implying a risk to public health., This work is part of the AGL-2013-45147-R funded by the Ministry of Science and Innovation (Madrid. Spain). The authors thank the UPV (Program of Research and Development) for funding the PhD scholarship FPI-2014 attained by P. Quintanilla.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Transfer of antibiotics from goat&apos, s milk to rennet curd and whey fractions during cheese-making

  • Giraldo, Jennifer
  • Igualada, Carmen
  • Cabizza, Roberto
  • Althaus, Rafael Lisandro
  • Beltrán Martínez, Mª Carmen|||0000-0002-5335-2179
[EN] The transfer of 35 antibiotics from milk to curd and whey was evaluated. Cheeses were produced at laboratory scale, from antibiotic-free goat's milk spiked with different antibiotic concentrations between 0.25 and 4 times the Maximum Residue Limits established in milk. Drug concentrations in milk, curd and whey were analysed by UHPLC-HRMS. Results indicated that most antibiotics were mainly transferred from milk to whey (up to 85.9%), with retention percentages in the curd lower than 50%, except for ceftiofur (59.7%) and dicloxacillin (52.8%). In most cases, drug distribution was unaffected by the antibiotic concentration in milk and correlated significantly to the drug lipophilicity (Log P) for beta-lactams (R-2 = 0.54) and sulfonamides (R-2 = 0.62). When drug ionization was considered (Log D), improved correlation coefficients were obtained for macrolides (R-2 = 0.98). However, other factors besides the drug solubility should be considered to explain and predict the partitioning of antibiotics during cheese-making., This work was supported by the Ministry of Science and Innovation (Madrid. Spain) (No. AGL-2013-45147-R) .